Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Gaki, K. Kontogianni, A. I. Papaioannou, P. Bakakos, K. I. Gourgoulianis, K. Kostikas, M. Alchanatis, S. Papiris, S. Loukides (Athens, Larisa, Greece). Associations between BODE index and systemic inflammatory biomarkers in COPD. Eur Respir J 2011; 38: Suppl. 55, 3515

Member's Comments

No comment yet.

Related content which might interest you: Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Can we assess COPD comorbidities by BODE index? Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Functional tests and relation to BODE index in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Assessment of functional status Year: 2009 Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Relationship between BODE index score, respiratory and peripheral muscle strength in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Clinical and inflammatory factors associated with body mass index in COPD patients Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Correlation of BODE index with extrapulmonary comorbidities of COPD patients Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Pulmonary rehabilitation effects on BODE index in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 The BODE index and other composite variables in COPD Source: Annual Congress 2013 –Composite variables in COPD and update of prevalence worldwide Year: 2013 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET) Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Biomarkers in COPD patients: Relationship with severity indices Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015